Prohibits pre-approval or precertification of prenatal ultrasound screenings covered under health benefits plans.
Impact
If enacted, S559 would have a significant impact on state laws governing health insurance regulations. By prohibiting pre-approval for prenatal ultrasound screenings, the bill seeks to enhance the timely provision of this critical healthcare service. It asserts that no health benefits plans should impose pre-approval conditions on procedures that are deemed medically necessary and are already covered under the specified health benefits. This could potentially lead to improved maternal health outcomes by reducing delays in receiving essential prenatal care.
Summary
Senate Bill 559, introduced in New Jersey, addresses the pre-approval and precertification requirements for prenatal ultrasound screenings covered by health benefits plans. The bill aims to eliminate the necessity for approval from health insurers or third-party administrators when the screening is prescribed by a healthcare provider. This move is expected to streamline access to necessary medical services for pregnant individuals, ensuring that they can receive prenatal ultrasounds without unnecessary bureaucratic hurdles.
Contention
While the bill's intent is largely supportive of patient access, there may be concerns regarding the implications for insurance carriers and their ability to manage healthcare costs and ensure appropriate medical necessity. Critics might argue that the lack of pre-approval could lead to increased costs for insurers, thus impacting premiums and ultimately consumers. However, supporters advocate that addressing the barriers to accessing essential prenatal care outweighs these concerns.
Prohibits pre-approval or precertification of medical tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.
Prohibits pre-approval or precertification of cancer treatments, tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.
Prohibits pre-approval or precertification of medical tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.
Requires health care professional to order bi-lateral ultrasounds concurrently when ordering mammograms; requires insurers to cover concurrent mammograms and bi-lateral ultrasounds.
Requires health care professionals to order bi-lateral ultrasounds concurrently when ordering mammograms; requires insurers to cover concurrent mammograms and bi-lateral ultrasounds.
Prohibits pre-approval or precertification of medical tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.
Prohibits pre-approval or precertification of medical tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.
Prohibits pre-approval or precertification of cancer treatments, tests, procedures and prescription drugs covered under health benefits or prescription drug benefits plans.
Enacts the "health insurance preauthorization disclosure act"; requires health insurance companies to provide participating health care providers with a list of health care treatments and services that require preauthorization from the health insurance company.
A nuclear energy generation tax credit; prioritizing nuclear energy resources; approval of certain electric tariffs for very large customers; and authorizing electric utilities to recover certain precertification costs through rates. (FE)